Inotrem will attend Immunotherapies & Innovations For Infectious Diseases 6th Congress. It is looking forward to meeting you at its lecture presenting the results of its last two clinical trials, ASTONISH and ESSENTIAL, targeting TREM-1 for the treatment of Septic Shock and Critically-Ill COVID-19 patients.
Accueil | Immunotherapies & Innovations for Infectious Diseases Congress | I4ID 2022